HealthCare Global Enterprises Ltd (BOM:539787)
₹ 677.15 +10.9 (+1.64%) Market Cap: 101.07 Bil Enterprise Value: 113.68 Bil PE Ratio: 702.03 PB Ratio: 7.59 GF Score: 83/100

Q4 2025 Healthcare Global Enterprises Ltd Earnings Call Transcript

May 26, 2025 / 05:00AM GMT
Release Date Price: ₹556.76 (-5.40%)

Key Points

Positve
  • HealthCare Global Enterprises Ltd (NSE:HCG) reported a strong operational and financial performance with a 20% revenue growth in Q4 and 17% for the full year.
  • The company is making significant investments in next-generation capabilities, including early cancer detection and precision medicine.
  • HCG has expanded its presence with the acquisition of MG Hospital in Vizag and the addition of five state-of-the-art LINAC accelerator machines.
  • Digital revenue has doubled over the past year, with the launch of the HCG Mobile App enhancing patient engagement and experience.
  • The company is focusing on expanding its network with plans to operationalize over 900 beds across its network within the next three years.
Negative
  • Margins are lower compared to other hospital chains, with emerging centers showing only a little over 10% margin.
  • The company faces challenges in international patient flow, particularly due to geopolitical issues affecting medical visas from Bangladesh.
  • Receivables were higher on a year-on-year basis, with some collections spilling over into the next quarter.
  • The Milann centers continue to struggle, and the company is considering divestment in this segment.
  • The company has a significant amount of debt, which has resulted in higher interest costs and is exploring primary equity to reduce this burden.
Operator

Ladies and gentlemen, welcome to the Q4 and FY25 earnings conference call of HealthCare Global Enterprises Limited. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as in the date of this call. These statements do not guarantee the future performance of the company, and it may involve risks and uncertainties that are difficult to predict.

(Operator Instructions) Please note that this conference is being recorded. Now, I hand over the conference to Dr. B.S. Ajaikumar, Executive Chairman of HealthCare Global Enterprises Limited. Thank you and over to you, sir.

Basavalinga Ajaikumar
Healthcare Global Enterprises Ltd - Executive Chairman of the Board

Thank you very much and good morning and warm welcome to all present on the Q4 and FY25 earnings conference for HealthCare Global Enterprise. Today I'm joined by our CEO, Mr. Raj Gore; Ruby Ritolia, our CFO; and senior management team along with our SGA, our Investor Relations Advisors.

We have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot